Clinical Trial Update: A Study of NILK-2301 in Patients with Locally Advanced or Metastatic Low Tumor Volume (LTV) Colorectal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating NILK-2301 in locally advanced or metastatic low tumor volume colorectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• NILK-2301

Snippet

Sponsor: Light Chain Bioscience - Novimmune SA | Conditions: Colorectal Cancer Metastatic | Phase 1 | Status: RECRUITING